AC

Arcadian Capital

North America, California, United States, Beverly Hills

Description

Arcadian Capital is a investment firm.

Investor Profile

Arcadian Capital has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Agriculture
  • Cannabis
  • Life Science
  • Medical
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Arcadian Capital frequently co-invest with?

Salveo Capital
North America, Illinois, United States, Chicago
Co-Investments: 2
Sand Hill Angels
North America, California, United States, Mountain View
Co-Investments: 1
Phyto Partners
North America, Florida, United States, Boca Raton
Co-Investments: 1
HBS Alumni Angels New York
North America, New York, United States, New York
Co-Investments: 1
Canna Angels
North America, California, United States, Sausalito
Co-Investments: 1
Militello Capital
North America, Virginia, United States, Leesburg
Co-Investments: 1
AFI Capital Partners
North America, Washington, United States, Seattle
Co-Investments: 1
Cthulhu Ventures
North America, California, United States, Sausalito
Co-Investments: 1
New York Angels
North America, New York, United States, New York
Co-Investments: 1
HALLEY Venture Partners
North America, California, United States, Lafayette
Co-Investments: 1

What are some of recent deals done by Arcadian Capital?

Front Range Biosciences

Boulder, Colorado, United States

Front Range Biosciences brings modern agriculture to improve reliability, efficiency, and safety for cultivators and consumers.

AgricultureBiotechnologyCannabisLife ScienceMedical
Series BFeb 14, 2020
Amount Raised: $18,746,174
KelSie Biotech

Boulder, Colorado, United States

KelSie Biotech develops high bioavailability delivery methods to formulate and deliver sensitive active pharmaceutical ingredients.

BiotechnologyHealth CarePharmaceutical
Series AMay 31, 2019
Amount Raised: $5,000,000